This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Clarivate | |
|---|---|
| Name | Clarivate |
| Type | Public |
| Industry | Information services |
| Founded | 2016 |
| Headquarters | Philadelphia, Pennsylvania |
| Key people | Jerre Stead |
| Products | Web of Science, Derwent Innovation, Cortellis |
| Revenue | (see Financial performance) |
Clarivate is an information services and analytics company formed in 2016 through a combination of legacy units and a private equity spin-off. The company operates global databases and analytics products used by universities, pharmaceutical firms, law firms, and government-funded research organizations. Clarivate provides citation indexing, patent analytics, drug pipeline intelligence, trademark management, and academic impact assessment to clients including academic institutions, corporations, and intellectual property practitioners.
Clarivate emerged from a background of legacy organizations with roots in bibliometrics and intellectual property services, including assets from Thomson Reuters and earlier entities such as Institute for Scientific Information and Derwent. Major milestones intersect with events involving private equity firms Onex Corporation, Baring Private Equity Asia, and Canada Pension Plan Investment Board during the 2010s. The company completed an initial public offering in the late 2010s and expanded through acquisitions that connected it to firms with histories at Elsevier, ProQuest, Springer Nature, LexisNexis, and Wiley. Strategic decisions were influenced by market dynamics shaped by actors such as Blackstone Group, KKR, Silver Lake Partners, and regulatory developments in jurisdictions including the United Kingdom, United States, and European Union.
Clarivate's governance framework includes a board of directors, executive leadership, and regional management reporting into headquarters in the United States while operating major offices in Europe and Asia. Board membership and executive appointments have involved individuals with prior roles at institutions like Goldman Sachs, Morgan Stanley, American Express, Pfizer, and Johnson & Johnson. Corporate governance practices reference listing requirements from exchanges such as New York Stock Exchange and interact with regulators including the Securities and Exchange Commission and corporate law regimes in Delaware and England and Wales. Shareholders have included institutional investors and pension funds connected to CalPERS, ABP (Netherlands), and major asset managers such as Vanguard and BlackRock.
Clarivate markets offerings across intellectual property, scientific research, and competitive intelligence. Flagship products include a citation indexing platform with lineage tracing to databases used by researchers at Harvard University, University of Oxford, Stanford University, Massachusetts Institute of Technology, and University of Tokyo. Patent and trademark services are used by corporate legal departments at firms such as Siemens, Samsung Electronics, Toyota Motor Corporation, Roche, and Novartis. Pharmaceutical intelligence tools support development teams at GlaxoSmithKline, AstraZeneca, Merck & Co., Bristol Myers Squibb, and Eli Lilly and Company. Legal analytics and docket services are adopted by firms in the United States Court of Appeals for the Federal Circuit, European Patent Office, and national patent offices including the United States Patent and Trademark Office and Japan Patent Office.
Research analytics offerings build on bibliometric methods used by scholars affiliated with Clarivate-adjacent institutions such as National Institutes of Health, Wellcome Trust, European Research Council, Australian Research Council, and foundations like the Bill & Melinda Gates Foundation. Databases support literature discovery, citation analysis, and impact measurement for projects funded by bodies like Horizon Europe and agencies such as the National Science Foundation. Tools are integrated into workflows involving reference managers and platforms developed by organizations like Zotero, EndNote (product), and libraries at institutions including Columbia University and University of California, Berkeley.
Since its formation, Clarivate pursued growth via acquisitions and organic expansion, completing transactions that brought together businesses formerly associated with Thomson Reuters, Derwent World Patents Index, and niche analytics firms. Financial reporting aligns with standards used by firms listed alongside peers such as RELX, Elsevier (RELX)', and Springer Nature. Investment activity has involved private equity actors like Clarion Partners and corporate finance advisors from J.P. Morgan, Goldman Sachs, and Credit Suisse. Revenue streams derive from subscription models, enterprise contracts with multinationals, and licensing agreements with research institutions and publishers including Nature Publishing Group, Cell Press, and IEEE.
Clarivate has faced criticism typical of large data aggregators concerning pricing, access, and consolidation effects similar to debates around Elsevier, ProQuest, and LexisNexis. Stakeholders such as academic consortia including Jisc, university libraries at University of California, University of Cambridge, and advocacy groups like SPARC and Right to Research Coalition have raised concerns over subscription costs and negotiating leverage. Regulatory scrutiny and public commentary have referenced antitrust debates comparable to cases involving Microsoft, Google, and media consolidation inquiries conducted by authorities such as the Federal Trade Commission and the Competition and Markets Authority.
Clarivate publishes policies purportedly aligned with frameworks established by international organizations such as the United Nations, World Health Organization, and standards bodies including ISO entities. Compliance programs interact with anti-corruption regimes exemplified by the Foreign Corrupt Practices Act and UK Bribery Act. Corporate social responsibility initiatives touch on open science dialogues with funders like the Wellcome Trust and initiatives promoted by scholarly societies such as the American Association for the Advancement of Science and the Royal Society. Legal compliance and data governance efforts are shaped by privacy regimes including General Data Protection Regulation and national data protection authorities across Canada, India, and Brazil.
Category:Information companies